| Date Filed | Type | Description |
| 12/10/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/01/2010 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Sold 2,209,741 shares
@ $0
Sold 14,503 shares
@ $0
Sold 132,802 shares
@ $0 |
|
| 10/29/2010 |
4
| FHM III, LLC (10% Owner) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| STROMATT SCOTT (SVP and Chief Medical Officer) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| SCHNELL DAVID (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Saks Samuel R (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Mohler Kendall (SVP & Chief Scientific Officer) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Mann David A (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Hove Anders D (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Heron Patrick J (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| GILLIS STEVEN (Ex. Chair. & President) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| MCKEREGHAN KATHLEEN (SVP and General Counsel) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| BURRIS MICHELLE (Senior V.P. and C.O.O.) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Disposed/sold 79,732 options to buy
@ $6.52, valued at
$519.9k
Disposed/sold 52,000 options to buy
@ $8.98, valued at
$467k
Disposed/sold 27,500 options to buy
@ $1.33, valued at
$36.6k
Disposed/sold 50,000 options to buy
@ $1.33, valued at
$66.5k
Disposed/sold 45,000 options to buy
@ $3.82, valued at
$171.9k
|
|
| 10/28/2010 |
4
| Brettman Lee R (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Bencich John (V.P. and CFO) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 09/27/2010 |
3
| ABBOTT LABORATORIES (10% Owner) has filed a Form 3 on Trubion Pharmaceuticals, Inc |
| 09/27/2010 |
4
| ABBOTT BIOTHERAPEUTICS CORP (10% Owner) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 02/01/2010 |
4
| STROMATT SCOTT (SVP and Chief Medical Officer) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 02/01/2010 |
4
| Mohler Kendall (SVP & Chief Scientific Officer) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 02/01/2010 |
4
| MCKEREGHAN KATHLEEN (SVP and General Counsel) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 02/01/2010 |
4
| BURRIS MICHELLE (Senior V.P. and C.O.O.) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Granted 45,000 options to buy
@ $3.82, valued at
$171.9k
|
|
| 02/01/2010 |
4
| Bencich John (V.P. and CFO) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 11/19/2009 |
3
| Bencich John (V.P. and CFO) has filed a Form 3 on Trubion Pharmaceuticals, Inc |
| 11/17/2009 |
4
| GILLIS STEVEN (Ex. Chair. & President) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 09/03/2009 |
3
| FACET BIOTECH CORP (10% Owner) has filed a Form 3 on Trubion Pharmaceuticals, Inc |
| 08/28/2009 |
4
| Thompson Peter A (President and CEO) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 08/28/2009 |
4
| STROMATT SCOTT (SVP and Chief Medical Officer) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 08/28/2009 |
4
| Mohler Kendall (SVP Research and Development) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 08/28/2009 |
4
| MCKEREGHAN KATHLEEN (SVP and General Counsel) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 08/28/2009 |
4
| BURRIS MICHELLE (Senior V.P. and C.F.O.) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 05/28/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 05/28/2009 |
4
| Saks Samuel R (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 05/28/2009 |
4
| Mann David A (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 05/28/2009 |
4
| Hove Anders D (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
|